Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Capanni

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Current Opinion in Hematology|October 18, 2001
Cellular therapy: exploiting NK cell alloreactivity in transplantationL Ruggeri, M Capanni, M F Martelli, et al.
The British Journal of Oral & Maxillofacial Surgery|December 28, 2024
Oral and Maxillofacial Surgery Curriculum (2021) and Oral Surgery Curriculum (2023): A forensic comparison of two documentsP M Capanni, S Magill, T Walker, et al.
Journal of Chemotherapy (Florence, Italy)|June 1, 2005
Reversible alopecia universalis during treatment with PEG-interferon and ribavirin for chronic hepatitis CG Taliani, E Biliotti, M Capanni, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 29, 2002
Need of more frequent International Normalized Ratio monitoring in elderly patients on long-term anticoagulant therapy after influenza vaccinationD Poli, L Chiarugi, M Capanni, et al.
The Journal of Experimental Medicine|June 22, 1999
Natural killer cell-mediated lysis of autologous cells modified by gene therapyC Liberatore, M Capanni, N Albi, et al.
Cytotherapy|October 25, 2002
Innate immunity against hematological malignanciesL Ruggeri, M Capanni, A Tosti, et al.
Thrombosis Research|September 11, 1998
Low-dose heparin pretreatment is not able to prevent clotting activation during coronary angiographyM Capanni, E Antonucci, L Chiarugi, et al.
Minerva Cardioangiologica|February 12, 2000
[Persistent generation of thrombin after coronary angioplasty]M Capanni, D Prisco, E Antonucci, et al.
Thrombosis Research|October 24, 2001
Postprocedural PAI-1 activity is a risk marker of subsequent clinical restenosis in patients both with and without stent implantation after elective balloon PTCAD Prisco, S Fedi, E Antonucci, et al.
Thrombosis and Haemostasis|May 6, 1998
The high prevalence of thermolabile 5-10 methylenetetrahydrofolate reductase (MTHFR) in Italians is not associated to an increased risk for coronary artery disease (CAD)R Abbate, I Sardi, G Pepe, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Current Opinion in Hematology|October 18, 2001
Cellular therapy: exploiting NK cell alloreactivity in transplantationL Ruggeri, M Capanni, M F Martelli, et al.
The British Journal of Oral & Maxillofacial Surgery|December 28, 2024
Oral and Maxillofacial Surgery Curriculum (2021) and Oral Surgery Curriculum (2023): A forensic comparison of two documentsP M Capanni, S Magill, T Walker, et al.
Journal of Chemotherapy (Florence, Italy)|June 1, 2005
Reversible alopecia universalis during treatment with PEG-interferon and ribavirin for chronic hepatitis CG Taliani, E Biliotti, M Capanni, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 29, 2002
Need of more frequent International Normalized Ratio monitoring in elderly patients on long-term anticoagulant therapy after influenza vaccinationD Poli, L Chiarugi, M Capanni, et al.
The Journal of Experimental Medicine|June 22, 1999
Natural killer cell-mediated lysis of autologous cells modified by gene therapyC Liberatore, M Capanni, N Albi, et al.
Cytotherapy|October 25, 2002
Innate immunity against hematological malignanciesL Ruggeri, M Capanni, A Tosti, et al.
Thrombosis Research|September 11, 1998
Low-dose heparin pretreatment is not able to prevent clotting activation during coronary angiographyM Capanni, E Antonucci, L Chiarugi, et al.
Minerva Cardioangiologica|February 12, 2000
[Persistent generation of thrombin after coronary angioplasty]M Capanni, D Prisco, E Antonucci, et al.
Thrombosis Research|October 24, 2001
Postprocedural PAI-1 activity is a risk marker of subsequent clinical restenosis in patients both with and without stent implantation after elective balloon PTCAD Prisco, S Fedi, E Antonucci, et al.
Thrombosis and Haemostasis|May 6, 1998
The high prevalence of thermolabile 5-10 methylenetetrahydrofolate reductase (MTHFR) in Italians is not associated to an increased risk for coronary artery disease (CAD)R Abbate, I Sardi, G Pepe, et al.
Pageof 3